This site is intended for healthcare professionals only
LoginRegister

Dermatology Dialogues

Biocon inaugurates first US manufacturing facility in New Jersey

Biocon Biologics, Sandoz ink pact for distribution of immune disorder injection Adalimumab in Japan

Adalimumab BS for subcutaneous injection [FKB] is a biosimilar of Humira (generic name: adalimumab (genetical recombination)) and is indicated for...
View All

Latest News and Guidelines

Increased Skin Cancer Risk in Lower Extremity Lymphedema Patients

Increased Skin Cancer Risk in Lower Extremity Lymphedema Patients

Gluconolactone with multiple skin benefits ideal for use in cosmetic and dermatologic procedures

Gluconolactone with multiple skin benefits ideal for use in cosmetic and dermatologic procedures

FDA approves birch triterpenes gel as topical medication for epidermolysis bullosa

FDA approves birch triterpenes gel as topical medication for epidermolysis bullosa

New guidelines released for treatment of anaphylaxis and atopic dermatitis

New guidelines released for treatment of anaphylaxis and atopic dermatitis

Omalizumab safely manages Chronic spontaneous urticaria during pregnancy

Omalizumab safely manages Chronic spontaneous urticaria during pregnancy

Roflumilast topical foam receives FDA approval for treating seborrheic dermatitis

Roflumilast topical foam receives FDA approval for treating seborrheic dermatitis

View All
X